These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 26723896)

  • 1. Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats.
    Úbeda M; Lario M; Muñoz L; Borrero MJ; Rodríguez-Serrano M; Sánchez-Díaz AM; Del Campo R; Lledó L; Pastor Ó; García-Bermejo L; Díaz D; Álvarez-Mon M; Albillos A
    J Hepatol; 2016 May; 64(5):1049-1057. PubMed ID: 26723896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats.
    Verbeke L; Farre R; Verbinnen B; Covens K; Vanuytsel T; Verhaegen J; Komuta M; Roskams T; Chatterjee S; Annaert P; Vander Elst I; Windmolders P; Trebicka J; Nevens F; Laleman W
    Am J Pathol; 2015 Feb; 185(2):409-19. PubMed ID: 25592258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term cannabinoid type 2 receptor agonist therapy decreases bacterial translocation in rats with cirrhosis and ascites.
    Yang YY; Hsieh SL; Lee PC; Yeh YC; Lee KC; Hsieh YC; Wang YW; Lee TY; Huang YH; Chan CC; Lin HC
    J Hepatol; 2014 Nov; 61(5):1004-13. PubMed ID: 24953022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl
    Xu H; Xiong J; Xu J; Li S; Zhou Y; Chen D; Cai X; Ping J; Deng M; Chen J
    Dig Dis Sci; 2017 Oct; 62(10):2801-2811. PubMed ID: 28815345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal Immune Dysregulation Driven by Dysbiosis Promotes Barrier Disruption and Bacterial Translocation in Rats With Cirrhosis.
    Muñoz L; Borrero MJ; Úbeda M; Conde E; Del Campo R; Rodríguez-Serrano M; Lario M; Sánchez-Díaz AM; Pastor O; Díaz D; García-Bermejo L; Monserrat J; Álvarez-Mon M; Albillos A
    Hepatology; 2019 Sep; 70(3):925-938. PubMed ID: 30414342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats.
    Ceulemans LJ; Verbeke L; Decuypere JP; Farré R; De Hertogh G; Lenaerts K; Jochmans I; Monbaliu D; Nevens F; Tack J; Laleman W; Pirenne J
    PLoS One; 2017; 12(1):e0169331. PubMed ID: 28060943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis.
    Sánchez E; Nieto JC; Boullosa A; Vidal S; Sancho FJ; Rossi G; Sancho-Bru P; Oms R; Mirelis B; Juárez C; Guarner C; Soriano G
    Liver Int; 2015 Mar; 35(3):735-45. PubMed ID: 24750552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development.
    Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M
    J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats.
    Lorenzo-Zúñiga V; Rodríguez-Ortigosa CM; Bartolí R; Martínez-Chantar ML; Martínez-Peralta L; Pardo A; Ojanguren I; Quiroga J; Planas R; Prieto J
    Gut; 2006 Sep; 55(9):1306-12. PubMed ID: 16434425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis.
    Llovet JM; Bartolí R; Planas R; Cabré E; Jimenez M; Urban A; Ojanguren I; Arnal J; Gassull MA
    Gut; 1994 Nov; 35(11):1648-52. PubMed ID: 7828991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats.
    Zhao TY; Su LP; Ma CY; Zhai XH; Duan ZJ; Zhu Y; Zhao G; Li CY; Wang LX; Yang D
    BMC Gastroenterol; 2015 Jul; 15():77. PubMed ID: 26152281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnane X receptor activation by its natural ligand Ginkgolide-A improves tight junction proteins expression and attenuates bacterial translocation in cirrhosis.
    Mohandas S; Vairappan B
    Chem Biol Interact; 2020 Jan; 315():108891. PubMed ID: 31697926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal mucosal oxidative damage and bacterial translocation in cirrhotic rats.
    Chiva M; Guarner C; Peralta C; Llovet T; Gómez G; Soriano G; Balanzó J
    Eur J Gastroenterol Hepatol; 2003 Feb; 15(2):145-50. PubMed ID: 12560758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active Vitamin D
    Lee PC; Hsieh YC; Huo TI; Yang UC; Lin CH; Li CP; Huang YH; Hou MC; Lin HC; Lee KC
    Mol Nutr Food Res; 2021 Feb; 65(3):e2000937. PubMed ID: 33258263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites.
    Pérez-Paramo M; Muñoz J; Albillos A; Freile I; Portero F; Santos M; Ortiz-Berrocal J
    Hepatology; 2000 Jan; 31(1):43-8. PubMed ID: 10613726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats.
    Lorenzo-Zúñiga V; Bartolí R; Planas R; Hofmann AF; Viñado B; Hagey LR; Hernández JM; Mañé J; Alvarez MA; Ausina V; Gassull MA
    Hepatology; 2003 Mar; 37(3):551-7. PubMed ID: 12601352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease.
    Zhang DY; Zhu L; Liu HN; Tseng YJ; Weng SQ; Liu TT; Dong L; Shen XZ
    Drug Des Devel Ther; 2019; 13():2249-2270. PubMed ID: 31308634
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis.
    Sánchez E; Casafont F; Guerra A; de Benito I; Pons-Romero F
    Rev Esp Enferm Dig; 2005 Nov; 97(11):805-14. PubMed ID: 16438624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interleukin 10 in norfloxacin prevention of luminal free endotoxin translocation in mice with cirrhosis.
    Gómez-Hurtado I; Moratalla A; Moya-Pérez Á; Peiró G; Zapater P; González-Navajas JM; Giménez P; Such J; Sanz Y; Francés R
    J Hepatol; 2014 Oct; 61(4):799-808. PubMed ID: 24882049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.